科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/09/22 | 5,800 | 5,810 | 5,730 | 5,760 | ±0 | ±0% | 84,600 |
2017/09/21 | 5,860 | 5,900 | 5,750 | 5,760 | -120 | -2% | 153,500 |
2017/09/20 | 5,850 | 5,900 | 5,830 | 5,880 | +50 | +0.9% | 168,300 |
2017/09/19 | 5,800 | 5,840 | 5,760 | 5,830 | +30 | +0.5% | 123,600 |
2017/09/15 | 5,800 | 5,850 | 5,790 | 5,800 | +10 | +0.2% | 178,300 |
2017/09/14 | 5,690 | 5,840 | 5,670 | 5,790 | +140 | +2.5% | 190,800 |
2017/09/13 | 5,680 | 5,720 | 5,630 | 5,650 | -80 | -1.4% | 296,500 |
2017/09/12 | 5,800 | 5,820 | 5,720 | 5,730 | -20 | -0.3% | 86,300 |
2017/09/11 | 5,730 | 5,800 | 5,710 | 5,750 | +90 | +1.6% | 114,200 |
2017/09/08 | 5,640 | 5,690 | 5,640 | 5,660 | -40 | -0.7% | 107,600 |
2017/09/07 | 5,660 | 5,770 | 5,650 | 5,700 | +30 | +0.5% | 138,000 |
2017/09/06 | 5,600 | 5,690 | 5,570 | 5,670 | +40 | +0.7% | 79,400 |
2017/09/05 | 5,680 | 5,680 | 5,610 | 5,630 | -30 | -0.5% | 103,900 |
2017/09/04 | 5,790 | 5,800 | 5,650 | 5,660 | -160 | -2.7% | 95,000 |
2017/09/01 | 5,820 | 5,850 | 5,770 | 5,820 | +10 | +0.2% | 87,800 |
2017/08/31 | 5,820 | 5,820 | 5,750 | 5,810 | +30 | +0.5% | 126,600 |
2017/08/30 | 5,750 | 5,810 | 5,740 | 5,780 | +20 | +0.3% | 91,700 |
2017/08/29 | 5,750 | 5,790 | 5,710 | 5,760 | -40 | -0.7% | 117,400 |
2017/08/28 | 5,680 | 5,810 | 5,680 | 5,800 | +140 | +2.5% | 96,100 |
2017/08/25 | 5,680 | 5,700 | 5,640 | 5,660 | ±0 | ±0% | 66,000 |
2017/08/24 | 5,640 | 5,690 | 5,640 | 5,660 | -20 | -0.4% | 66,200 |
2017/08/23 | 5,680 | 5,710 | 5,670 | 5,680 | -10 | -0.2% | 67,300 |
2017/08/22 | 5,680 | 5,700 | 5,670 | 5,690 | ±0 | ±0% | 63,900 |
2017/08/21 | 5,700 | 5,780 | 5,680 | 5,690 | -10 | -0.2% | 96,500 |
2017/08/18 | 5,700 | 5,720 | 5,660 | 5,700 | -70 | -1.2% | 84,000 |
2017/08/17 | 5,740 | 5,800 | 5,720 | 5,770 | +40 | +0.7% | 82,000 |
2017/08/16 | 5,690 | 5,730 | 5,620 | 5,730 | +40 | +0.7% | 139,100 |
2017/08/15 | 5,710 | 5,710 | 5,640 | 5,690 | +80 | +1.4% | 107,900 |
2017/08/14 | 5,620 | 5,640 | 5,600 | 5,610 | -110 | -1.9% | 139,600 |
2017/08/10 | 5,700 | 5,730 | 5,680 | 5,720 | +40 | +0.7% | 110,500 |
2017/08/09 | 5,710 | 5,730 | 5,650 | 5,680 | -50 | -0.9% | 131,300 |
2017/08/08 | 5,750 | 5,760 | 5,710 | 5,730 | +10 | +0.2% | 115,800 |
2017/08/07 | 5,780 | 5,780 | 5,710 | 5,720 | -30 | -0.5% | 109,500 |
2017/08/04 | 5,780 | 5,780 | 5,750 | 5,750 | -40 | -0.7% | 92,300 |
2017/08/03 | 5,870 | 5,880 | 5,750 | 5,790 | -130 | -2.2% | 295,200 |
2017/08/02 | 6,080 | 6,080 | 5,900 | 5,920 | -200 | -3.3% | 268,700 |
2017/08/01 | 5,960 | 6,140 | 5,940 | 6,120 | +240 | +4.1% | 443,700 |
2017/07/31 | 5,910 | 5,930 | 5,870 | 5,880 | -80 | -1.3% | 172,400 |
2017/07/28 | 5,960 | 5,980 | 5,910 | 5,960 | -30 | -0.5% | 113,700 |
2017/07/27 | 6,010 | 6,060 | 5,980 | 5,990 | +10 | +0.2% | 120,800 |
2017/07/26 | 5,910 | 6,000 | 5,900 | 5,980 | +60 | +1% | 119,500 |
2017/07/25 | 5,970 | 5,990 | 5,920 | 5,920 | -60 | -1% | 83,000 |
2017/07/24 | 5,970 | 5,990 | 5,940 | 5,980 | -10 | -0.2% | 111,300 |
2017/07/21 | 6,030 | 6,040 | 5,970 | 5,990 | -80 | -1.3% | 98,000 |
2017/07/20 | 5,990 | 6,090 | 5,980 | 6,070 | +100 | +1.7% | 161,600 |
2017/07/19 | 5,930 | 6,000 | 5,930 | 5,970 | +30 | +0.5% | 121,800 |
2017/07/18 | 5,990 | 6,010 | 5,910 | 5,940 | -80 | -1.3% | 143,300 |
2017/07/14 | 5,950 | 6,040 | 5,950 | 6,020 | +70 | +1.2% | 130,900 |
2017/07/13 | 6,010 | 6,060 | 5,950 | 5,950 | -50 | -0.8% | 114,200 |
2017/07/12 | 6,050 | 6,060 | 6,000 | 6,000 | -70 | -1.2% | 98,000 |
1851~
1900
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム